Literature DB >> 34542739

miR-511-5p Suppresses Cell Migration, Invasion and Epithelial-Mesenchymal Transition Through Targeting PAK2 in Gastric Cancer.

Wenjing Yong1, Ke Zhang2, Youming Deng2, Weisen Tang2, Ran Tao3.   

Abstract

As a malignant tumor, gastric cancer (GC) is closely related with gastric mucosa and has a high mortality in the world. Since microRNA (miRNA) has become more and more important in tumor research, we intend to find out the functional role and mechanism of miR-511-5p in GC. Firstly, miR-511-5p level was examined in human GC cell lines and tissues, and its effect on cell migration and invasion of BGC-823 or HGC-27 cells was tested by migration assay and transwell assay. Then, we confirmed the association between miR-511-5p and p21 activated kinase 2 (PAK2) by the luciferase reporter assay, and further assessed their role in cell migration and invasion. Moreover, we verified the function of miR-511-5p and PAK2 in epithelial-mesenchymal transition (EMT). In our study, miR-511-5p was downregulated in GC cell lines and tissues, and inversely associated with PAK2. Luciferase reporter assay confirmed that miR-511-5p could bind to PAK2. MiR-511-5p mimics significantly upregulated E-cadherin and downregulated N-cadherin, Vimentin and Snail, and consequently inhibited cell migration and invasion. However, reintroduction of PAK2 reversed the inhibitory function of miR-511-5p on BGC-823 and HGC-27 cells. Our research suggested that tumor-suppressive function of miR-511-5p in GC was inhibited by PAK2, and miR-511-5p/PAK2 axis may serve as a new strategy in GC management.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cell migration and invasion; EMT; Gastric cancer; PAK2; miR-511-5p

Mesh:

Substances:

Year:  2021        PMID: 34542739     DOI: 10.1007/s10528-021-10126-y

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  31 in total

Review 1.  Breast cancer and microRNAs: therapeutic impact.

Authors:  Marilena V Iorio; Patrizia Casalini; Claudia Piovan; Luca Braccioli; Elda Tagliabue
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

Review 2.  The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.

Authors:  Lidia Rita Corsini; Giuseppe Bronte; Marianna Terrasi; Valeria Amodeo; Daniele Fanale; Eugenio Fiorentino; Giuseppe Cicero; Viviana Bazan; Antonio Russo
Journal:  Expert Opin Ther Targets       Date:  2012-03-23       Impact factor: 6.902

3.  Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.

Authors:  Hee Jun Cho; Kyoung Eun Baek; In-Kyu Kim; Sun-Mi Park; Yeong-Lim Choi; In-Koo Nam; Seung-Ho Park; Min-Ju Im; Jong-Min Yoo; Ki-Jun Ryu; Young Taek Oh; Soon-Chan Hong; Oh-Hyung Kwon; Jae Won Kim; Chang Won Lee; Jiyun Yoo
Journal:  J Proteome Res       Date:  2012-03-12       Impact factor: 4.466

4.  Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.

Authors:  Shingo Hamano; Yoshinori Mori; Mineyoshi Aoyama; Hiromi Kataoka; Mamoru Tanaka; Masahide Ebi; Eiji Kubota; Tsutomu Mizoshita; Satoshi Tanida; Randal N Johnston; Kiyofumi Asai; Takashi Joh
Journal:  Cancer Lett       Date:  2014-11-17       Impact factor: 8.679

5.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

6.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

7.  MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.

Authors:  Xin-Bo Chen; Wei Li; Ai-Xia Chu
Journal:  J Cell Biochem       Date:  2018-08-30       Impact factor: 4.429

8.  MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.

Authors:  Na Huang; Zhenzhen Wu; Li Lin; Minyu Zhou; Lin Wang; Huanrong Ma; Jianling Xia; Jianping Bin; Yulin Liao; Wangjun Liao
Journal:  Oncotarget       Date:  2015-06-20

9.  Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.

Authors:  Ziling Fang; Ling Zhang; Quan Liao; Yi Wang; Feng Yu; Miao Feng; Xiaojun Xiang; Jianping Xiong
Journal:  J Exp Clin Cancer Res       Date:  2017-01-23

10.  Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.

Authors:  Chengcheng Gao; Tianheng Ma; Liqun Pang; Rui Xie
Journal:  Diagn Pathol       Date:  2014-03-12       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.